Home Healthcare Biotechnology Virology Market

Virology Market Size, Share & Trends Analysis Report By Type (Diagnosing Test, Viral Infection, Controlling Methods, Antiviral Therapeutics, Interferon), By Applications (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract Infections, Eye Infections, CNS Infections, Others), By End-Users (Hospitals, Clinics, Diagnostic Centers, Blood Banks, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 04, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Virology Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Diagnosing Test 
    2. Viral Infection 
    3. Controlling Methods 
    4. Antiviral Therapeutics
    5. Interferon
  2. Virology Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Skin and Soft Tissue Infections 
    2. Respiratory Tract Infections 
    3. GI Tract Infections 
    4. Urinary Tract Infections 
    5. Eye Infections 
    6. CNS Infections 
    7. Others
  3. Virology Market, By End-Users 2022-2034 (USD MILLION/ Units)
    1. Hospitals 
    2. Clinics 
    3. Diagnostic Centers 
    4. Blood Banks 
    5. Others
  4. Regional Virology Market
    1. North America
      1. North America Virology Market By Type 2022-2034 (USD MILLION/ Units)
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
      2. North America Virology Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Skin and Soft Tissue Infections 
        2. Respiratory Tract Infections 
        3. GI Tract Infections 
        4. Urinary Tract Infections 
        5. Eye Infections 
        6. CNS Infections 
        7. Others
      3. North America Virology Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Diagnostic Centers 
        4. Blood Banks 
        5. Others
      4. U.S.
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      5. Canada
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
    2. Europe
      1. Europe Virology Market By Type 2022-2034 (USD MILLION/ Units)
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
      2. Europe Virology Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Skin and Soft Tissue Infections 
        2. Respiratory Tract Infections 
        3. GI Tract Infections 
        4. Urinary Tract Infections 
        5. Eye Infections 
        6. CNS Infections 
        7. Others
      3. Europe Virology Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Diagnostic Centers 
        4. Blood Banks 
        5. Others
      4. U.K.
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      5. Germany
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      6. France
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      7. Spain
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      8. Italy
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      9. Russia
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      10. Nordic
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      11. Benelux
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      12. Rest of Europe
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
    3. APAC
      1. APAC Virology Market By Type 2022-2034 (USD MILLION/ Units)
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
      2. APAC Virology Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Skin and Soft Tissue Infections 
        2. Respiratory Tract Infections 
        3. GI Tract Infections 
        4. Urinary Tract Infections 
        5. Eye Infections 
        6. CNS Infections 
        7. Others
      3. APAC Virology Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Diagnostic Centers 
        4. Blood Banks 
        5. Others
      4. China
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      5. Korea
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      6. Japan
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      7. India
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      8. Australia
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      9. Taiwan
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      10. South East Asia
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      11. Rest of Asia-Pacific
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
    4. Middle East and Africa
      1. Middle East and Africa Virology Market By Type 2022-2034 (USD MILLION/ Units)
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
      2. Middle East and Africa Virology Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Skin and Soft Tissue Infections 
        2. Respiratory Tract Infections 
        3. GI Tract Infections 
        4. Urinary Tract Infections 
        5. Eye Infections 
        6. CNS Infections 
        7. Others
      3. Middle East and Africa Virology Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Diagnostic Centers 
        4. Blood Banks 
        5. Others
      4. UAE
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      5. Turkey
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      6. Saudi Arabia
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      7. South Africa
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      8. Egypt
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      9. Nigeria
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      10. Rest of MEA
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
    5. LATAM
      1. LATAM Virology Market By Type 2022-2034 (USD MILLION/ Units)
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
      2. LATAM Virology Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Skin and Soft Tissue Infections 
        2. Respiratory Tract Infections 
        3. GI Tract Infections 
        4. Urinary Tract Infections 
        5. Eye Infections 
        6. CNS Infections 
        7. Others
      3. LATAM Virology Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals 
        2. Clinics 
        3. Diagnostic Centers 
        4. Blood Banks 
        5. Others
      4. Brazil
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      5. Mexico
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      6. Argentina
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      7. Chile
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      8. Colombia
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
      9. Rest of LATAM
        1. Diagnosing Test 
        2. Viral Infection 
        3. Controlling Methods 
        4. Antiviral Therapeutics
        5. Interferon
        6. Skin and Soft Tissue Infections 
        7. Respiratory Tract Infections 
        8. GI Tract Infections 
        9. Urinary Tract Infections 
        10. Eye Infections 
        11. CNS Infections 
        12. Others
        13. Hospitals 
        14. Clinics 
        15. Diagnostic Centers 
        16. Blood Banks 
        17. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.